Your browser doesn't support javascript.
loading
Compartment-specific mutational landscape of clonal hematopoiesis.
Hartmann, Luise; Hecker, Judith S; Rothenberg-Thurley, Maja; Rivière, Jennifer; Jentzsch, Madlen; Ksienzyk, Bianka; Buck, Michèle C; van der Garde, Mark; Fischer, Luise; Winter, Susann; Rauner, Martina; Tsourdi, Elena; Weidner, Heike; Sockel, Katja; Schneider, Marie; Kubasch, Anne S; Nolde, Martin; Hausmann, Dominikus; Lützner, Jörg; Goralski, Szymon; Bassermann, Florian; Spiekermann, Karsten; Hofbauer, Lorenz C; Schwind, Sebastian; Platzbecker, Uwe; Götze, Katharina S; Metzeler, Klaus H.
Afiliação
  • Hartmann L; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital (LMU), Munich, Germany.
  • Hecker JS; German Cancer Consortium (DKTK), CHOICE Consortium, Partner Sites, Munich/Dresden, Germany.
  • Rothenberg-Thurley M; German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Rivière J; German Cancer Consortium (DKTK), CHOICE Consortium, Partner Sites, Munich/Dresden, Germany.
  • Jentzsch M; German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Ksienzyk B; Department of Medicine III, Technical University of Munich (TUM), Klinikum rechts der Isar, Munich, Germany.
  • Buck MC; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital (LMU), Munich, Germany.
  • van der Garde M; Department of Medicine III, Technical University of Munich (TUM), Klinikum rechts der Isar, Munich, Germany.
  • Fischer L; Department of Hematology and Cell Therapy, University Hospital Leipzig (UHL), Leipzig, Germany.
  • Winter S; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital (LMU), Munich, Germany.
  • Rauner M; Department of Medicine III, Technical University of Munich (TUM), Klinikum rechts der Isar, Munich, Germany.
  • Tsourdi E; German Cancer Consortium (DKTK), CHOICE Consortium, Partner Sites, Munich/Dresden, Germany.
  • Weidner H; German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Sockel K; Department of Medicine III, Technical University of Munich (TUM), Klinikum rechts der Isar, Munich, Germany.
  • Schneider M; German Cancer Consortium (DKTK), CHOICE Consortium, Partner Sites, Munich/Dresden, Germany.
  • Kubasch AS; Department of Medicine I, University Hospital Carl Gustav Carus, Technical University of Dresden (TUD), Dresden, Germany.
  • Nolde M; German Cancer Consortium (DKTK), CHOICE Consortium, Partner Sites, Munich/Dresden, Germany.
  • Hausmann D; Department of Medicine I, University Hospital Carl Gustav Carus, Technical University of Dresden (TUD), Dresden, Germany.
  • Lützner J; German Cancer Consortium (DKTK), CHOICE Consortium, Partner Sites, Munich/Dresden, Germany.
  • Goralski S; Center for Healthy Aging, Technical University of Dresden (TUD), Dresden, Germany.
  • Bassermann F; German Cancer Consortium (DKTK), CHOICE Consortium, Partner Sites, Munich/Dresden, Germany.
  • Spiekermann K; Center for Healthy Aging, Technical University of Dresden (TUD), Dresden, Germany.
  • Hofbauer LC; German Cancer Consortium (DKTK), CHOICE Consortium, Partner Sites, Munich/Dresden, Germany.
  • Schwind S; Center for Healthy Aging, Technical University of Dresden (TUD), Dresden, Germany.
  • Platzbecker U; German Cancer Consortium (DKTK), CHOICE Consortium, Partner Sites, Munich/Dresden, Germany.
  • Götze KS; Department of Medicine I, University Hospital Carl Gustav Carus, Technical University of Dresden (TUD), Dresden, Germany.
  • Metzeler KH; German Cancer Consortium (DKTK), CHOICE Consortium, Partner Sites, Munich/Dresden, Germany.
Leukemia ; 36(11): 2647-2655, 2022 11.
Article em En | MEDLINE | ID: mdl-36131041
Clonal hematopoiesis (CH) is characterized by somatic mutations in blood cells of individuals without hematologic disease. While the mutational landscape of CH in peripheral blood (PB) has been well characterized, detailed analyses addressing its spatial and cellular distribution in the bone marrow (BM) compartment are sparse. We studied CH driver mutations in healthy individuals (n = 261) across different anatomical and cellular compartments. Variant allele frequencies were higher in BM than PB and positively correlated with the number of driver variants, yet remained stable during a median of 12 months of follow-up. In CH carriers undergoing simultaneous bilateral hip replacement, we detected ASXL1-mutant clones in one anatomical location but not the contralateral side, indicating intra-patient spatial heterogeneity. Analyses of lineage involvement in ASXL1-mutated CH showed enriched clonality in BM stem and myeloid progenitor cells, while lymphocytes were particularly involved in individuals carrying the c.1934dupG variant, indicating different ASXL1 mutations may have distinct lineage distribution patterns. Patients with overt myeloid malignancies showed higher mutation numbers and allele frequencies and a shifting mutation landscape, notably characterized by increasing prevalence of DNMT3A codon R882 variants. Collectively, our data provide novel insights into the genetics, evolution, and spatial and lineage-specific BM involvement of CH.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hematopoiese Clonal / Transtornos Mieloproliferativos Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hematopoiese Clonal / Transtornos Mieloproliferativos Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article